Stocktoria

CSL Limited CSL.AX

AU · Australian Securities Exchange · XASX · stock · Healthcare · website

CSL Limited statistics & valuation

P / S5.6×
P / B5.9×
Net margin-16.4%
Net debt$9.4B
Enterprise value$70.7B
Earnings yield EBIT/EV3.2%
Return on capital11%

Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
16.70% 18.00% 19.50% -16.40% 2023202420252026
Gross margin (%)
50.90% 51.50% 51.50% 50.80% 2023202420252026
Operating margin (%)
16.00% 18.80% 19.20% 19.80% 2023202420252026
Return on equity (%)
13.90% 15.20% 15.50% -17.40% 2023202420252026
Shares outstanding
479.9M 479.9M 479.9M 479.9M 2023202420252026
Net debt ($)
$10.68B $10.53B $9.34B $9.38B 2023202420252026
Share buybacks ($)
$724.0M 2023202420252026
Return on assets (%)
6.10% 6.90% 7.60% -7.70% 2023202420252026
Free cash flow margin (%)
2023202420252026
Debt / equity (×)
0.77× 0.70× 0.59× 0.74× 2023202420252026
EPS ($)
$4.53 $5.45 $6.17 -$5.35 2023202420252026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2026FY2025FY2024FY2023
Gross margin50.8%51.5%51.5%50.9%
Operating margin19.8%19.2%18.8%16.0%
Net margin-16.4%19.5%18.0%16.7%
Return on assets-7.7%7.6%6.9%6.1%
Return on equity-17.4%15.5%15.2%13.9%
Debt / equity0.57×0.47×0.56×0.61×
Current ratio2.212.462.182.01

Computed from company filings · AU · as of 2026-06-30. Figures in USD. Facts plus Stocktoria's own computed scores — not investment advice.